Here are relevant reports on : drug-safety-market
-
Drug Eluting Stents Market - 2019 By Types, Application & Geography
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Drug Discovery Outsourcing Market - 2019 By Types, Application & Geography
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Car Safety Market by System Type (Active Safety & Passive Safety), Safety Regulations by Region (APAC, Europe, North America & Rest of the World), Impact Analysis (Overall Market OEM, Tier I & Consumer) - Trends & Forecast to 2020
The car safety systems market is estimated to be USD 93.73 Billion in 2015, and is projected to reach 152.59 Billion by 2020, growing at a CAGR of 10.24%. The car safety systems market has witnessed considerable growth in countries such as the U.S., China, India, and Mexico, owing to the increasing vehicle electrification, rising vehicle production, and increasingly stringent safety norms.
- Published: January 2016
- Price: $ 4950
- TOC Available:
-
Motor Lamination Market by Application (Performance, Comfort, and Safety), Material, Technology, Motor Type (Power Steering & Window, Adaptive front light), ICE & Electric Vehicle, ATV by Application and Region - Global Forecast to 2027
The motor lamination market is projected to reach USD 27.6 billion by 2027 at a CAGR of 4.7% during the forecast period. The motor lamination market is dominated by a few global players and comprises several regional players. Some of the key manufacturers and suppliers of the motor lamination market are Tempel (US), Pitti Engineering Ltd (India), Alinabal, Inc (US), EuroGroup Laminations S.p.A. (Italy), R. Bourgeois (France), and LCS Company (US).
- Published: December 2022
- Price: $ 4950
- TOC Available:
-
Cell Based Assays Market by Offering (Consumables (Reagents, Assay Kits, Cell Lines, Microplates, Probes, Labels), Instruments & Software), Technology (Flow Cytometry, HTS), Application (Drug Discovery (Toxicity, PK/PD Studies)) - Global Forecast to 2030
The global cell-based assays market, valued at US$17.36B in 2024, is forecasted to grow at a 9.1% CAGR, reaching US$18.134B by 2025 and US$25.77B by 2030. Growth in this market is primarily driven by the increasing demand for drug discovery and development, the increasing preference for cell-based assays in drug discovery, and the rising prevalence of cancer.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
US Pharmaceutical Drug Delivery Market by Route of Administration [Oral (Tablet, Capsule), Injectable, Topical (Cream, Transdermal, Suppositories), Ocular, Nasal, Transmucosal, Implantable], Application (Cancer, Diabetes), Care Setting - Forecast to 2031
The US pharmaceutical drug delivery market, valued at US$0.91 billion in 2025, stood at US$0.94 billion in 2026 and is projected to advance at a resilient CAGR of 5.8% from 2026 to 2031, culminating in a forecasted valuation of US$1.24 billion by the end of the period. The market growth trend is fueled by several factors. One of the primary drivers is the quick and extensive rise of biologics and biosimilars, necessitating advanced injectable and large-volume delivery systems.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
High Altitude Equipment Market by Product Type (Survival, Safety, Medical Emergencies), Application (Recreational Activates, Military) & Geography - Global Forecasts to 2020
At high altitudes survival and safety becomes very important and getting through such environment requires certain type of gears and equipment. Survival without such equipment becomes very difficult. Medical emergencies need to be handled efficiently and with care. Equipment specifically designed for high altitude make it easier to handle such situations.. The atmosphere is very harsh and extreme at high altitudes, mostly adventure enthusiast or military personnel have to live in such conditions. The lack of oxygen at high altitudes can cause serious illnesses such as altitude sickness, high altitude pulmonary edema, and high altitude cerebral edema.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Push-to-talk Market by Offering (Hardware, Solutions, and Services), Network Type (LMR and Cellular), Vertical (Government & Public Safety, Aerospace & Defense, and Transportation & Logistics) and Region - Global Forecast to 2028
The push-to-talk (PTT) market is projected to reach USD 57.4 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period. The major vendors covered in the PTT market AT&T Inc. (US); Verizon Wireless (US); Motorola Solutions, Inc. (US); T-Mobile (US); Qualcomm Incorporated (US); Zebra Technologies Corporation (US); Telstra Group Limited (Australia); Hytera Communications Corporation Limited (China); Telefonaktiebolaget LM Ericsson (Sweden); Bell Canada (Canada); Iridium Communications Inc. (US); Tait Communications (New Zealand); Airbus SE (Netherlands); L3Harris Technologies, Inc. (US); ServiceMax, a PTC Technology (US); Simoco Wireless Solutions (UK); GroupTalk (Sweden); Orion Labs, Inc. (US); Zello Inc. (US); Procore Technologies, Inc. (US); VoxerNet LLC (US); International Push to Talk Ltd (England); Enterprise Secure Chat (US); AINA Wireless (US); Azetti Networks (Spain); PeakPTT (US); RugGear (China); ProMobi Technologies (India); and TeamConnect (US).
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Microscopy Market by Product [Optical Microscope: Stereo, Digital; Electron microscope: SEM, TEM, AFM, STM], Application (Pharma Mfg, Pathology, Drug Discovery, Toxicology), End User (Pharma-biopharma, Academia, Semiconductor) — Forecast to 2031
The Asia-Pacific microscopy market is projected to reach USD 2.56 billion by 2031, growing at a CAGR of 6.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Antibody Drug Conjugates (ADC) Market by Product (Kadcyla, Enhertu, Padcev, Polivy), Linker Type (Cleavable, Non-Cleavable), Payload Type (Calicheamicin, MMAE), Target (HER2, CD30, CD22), Disease, Region - Global Forecast to 2028
The global antibody drug conjugates market, valued at US$7.6 billion in 2022, stood at US$9.7 billion in 2023 and is projected to advance at a resilient CAGR of 15.2% from 2025 to 2028, culminating in a forecasted valuation of US$19.8 billion by the end of the period. Growth in the market can be attributed to various factors such as including the growing prevalence of cancer, and increasing R&D activities for the development of novel ADCs by key market players.
- Published: October 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
